McCann FitzGerald LLP
McCann FitzGerald LLP advises Alkermes plc on the completion of its acquisition of Avadel Pharmaceuticals plc
We are delighted to have advised Alkermes plc on the completion of its acquisition of Avadel Pharmaceuticals plc, a commercial-stage biopharmaceutical company in a deal valued at up to $2.37 billion.
The McCann FitzGerald LLP team was led by Stephen FitzSimons, Jack Kelly and Gill Lohan (Corporate and M&A), Mark O’Connor and Stuart McCarron (Debt Finance) and Alan Heuston (Tax). The team includes Jack O’Reilly, Clarissa Mulcahy and Ben Arrowsmith (Corporate and M&A), Riona Connaughton (Debt Finance), Deirdre Barnicle, James Quirke and Cian O’Rourke (Tax), Laura Treacy, Stephen Ryan and Andrea Higgins (Antitrust and Competition) and Mary Brassil and Dara O’Toole (Employment).
Select how you would like to share using the options below